PH27534A - Antoganists of gm-csf derived from the carboxyl terminus - Google Patents

Antoganists of gm-csf derived from the carboxyl terminus

Info

Publication number
PH27534A
PH27534A PH40830A PH40830A PH27534A PH 27534 A PH27534 A PH 27534A PH 40830 A PH40830 A PH 40830A PH 40830 A PH40830 A PH 40830A PH 27534 A PH27534 A PH 27534A
Authority
PH
Philippines
Prior art keywords
antoganists
carboxyl terminus
csf derived
csf
derived
Prior art date
Application number
PH40830A
Other languages
English (en)
Inventor
Gail Foure Seelig
Julie Ellen Scheffler
Paul Phillip Trotta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PH27534A publication Critical patent/PH27534A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243Colony Stimulating Factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
PH40830A 1989-07-14 1990-07-12 Antoganists of gm-csf derived from the carboxyl terminus PH27534A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37984689A 1989-07-14 1989-07-14

Publications (1)

Publication Number Publication Date
PH27534A true PH27534A (en) 1993-08-18

Family

ID=23498958

Family Applications (1)

Application Number Title Priority Date Filing Date
PH40830A PH27534A (en) 1989-07-14 1990-07-12 Antoganists of gm-csf derived from the carboxyl terminus

Country Status (16)

Country Link
US (1) US5475087A (es)
EP (2) EP0482086A1 (es)
JP (1) JPH04503815A (es)
KR (1) KR920701246A (es)
AU (1) AU630496B2 (es)
CA (1) CA2062975A1 (es)
FI (1) FI920150A0 (es)
HU (1) HUT63181A (es)
IE (1) IE902562A1 (es)
IL (1) IL95061A0 (es)
MY (1) MY105946A (es)
NO (1) NO920176D0 (es)
NZ (1) NZ234479A (es)
PH (1) PH27534A (es)
WO (1) WO1991001330A1 (es)
ZA (1) ZA905480B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2060741A1 (en) * 1991-02-11 1992-08-12 Robert S. Greenfield Gm-csf inhibiting oligopeptides
AU5611394A (en) * 1992-11-19 1994-06-08 Dana-Farber Cancer Institute Antibodies for gm-csf receptor and uses thereof
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
FR2730154B1 (fr) * 1995-02-08 1997-07-11 Stephanois Rech Dispositif de mesure des efforts exerces lors de la marche
AUPN378095A0 (en) * 1995-06-23 1995-07-20 Bresagen Limited Haemopoietic growth factor antagonists and uses therefor
US8062637B2 (en) * 2000-05-08 2011-11-22 Morphosys Ag Methods of ameliorating inflammatory disease using an uPA antagonist
US7455836B2 (en) * 2000-05-08 2008-11-25 The University Of Melbourne Method of treatment and agents useful for same
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
EP1712241A1 (en) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition for treating cancer adapted for intra-tumoral administration and uses thereof
AU2005100402B4 (en) * 2005-05-16 2006-01-12 Novomatic Ag Method for increased chances at an award on a Gaming Machine
EP3181585A3 (en) 2006-02-08 2017-08-30 Morphotek, Inc. Antigenic gm-csf peptides and antibodies to gm-csf
AU2013201228B2 (en) * 2006-02-08 2016-01-21 Eisai, Inc. Antigenic gm-csf peptides and antibodies to gm-csf
EP2402013A1 (en) * 2006-11-21 2012-01-04 Kalobios Pharmaceuticals, Inc. Methods of Treating Chronic Inflammatory Diseases using a GM-CSF Antagonist
US8398972B2 (en) 2006-11-21 2013-03-19 Kalobios Pharmaceuticals, Inc. Methods of treating dementia using a GM-CSF antagonist
TW200918553A (en) * 2007-09-18 2009-05-01 Amgen Inc Human GM-CSF antigen binding proteins
EP2215119B1 (en) 2007-11-13 2012-12-26 Evec Inc. Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
CN102271705A (zh) 2008-12-22 2011-12-07 墨尔本大学 骨关节炎治疗
JP5674677B2 (ja) * 2008-12-22 2015-02-25 ザ ユニバーシティー オブ メルボルンThe University of Melbourne 疼痛治療
US9901079B2 (en) 2011-08-18 2018-02-27 New York University Inhibition of oncogenic kras-induced GM-CSF production and function
CA2856329A1 (en) 2011-11-17 2013-05-23 Nencki Institute Of Experimental Biology Compositions and methods for treating glioma
CA3211107A1 (en) 2021-02-15 2022-08-18 Splifar S.A. Method for applying a seal to a plate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
ATE67244T1 (de) * 1984-07-06 1991-09-15 Sandoz Ag Herstellung und reinigung von lymphokinen.
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
AU6148790A (en) 1991-02-22
KR920701246A (ko) 1992-08-11
IE902562A1 (en) 1991-02-27
WO1991001330A1 (en) 1991-02-07
NZ234479A (en) 1992-03-26
NO920176L (no) 1992-01-14
HUT63181A (en) 1993-07-28
IL95061A0 (en) 1991-06-10
EP0482086A1 (en) 1992-04-29
HU9200087D0 (en) 1992-04-28
ZA905480B (en) 1991-03-27
MY105946A (en) 1995-02-28
EP0409091A1 (en) 1991-01-23
AU630496B2 (en) 1992-10-29
CA2062975A1 (en) 1991-01-15
US5475087A (en) 1995-12-12
FI920150A0 (fi) 1992-01-14
NO920176D0 (no) 1992-01-14
JPH04503815A (ja) 1992-07-09

Similar Documents

Publication Publication Date Title
PH27534A (en) Antoganists of gm-csf derived from the carboxyl terminus
EP0417959A3 (en) An assembly for locating the position of an object
IL94699A0 (en) Imidazolyl-alkenoic acids
IL96765A0 (en) Modification of the expression characteristics of an endogenous gene
GB2215150B (en) Signal conditioners
ZA902510B (en) 5-alkylquinolonecarboxylic acids
GB9009275D0 (en) Pipe flange connections
AU586921B2 (en) Coil coated metal
YU39388A (en) Flange connection
EP0502099A4 (en) Chimeric proteins
AU631399B2 (en) Novel novolaks of the phenol-dense aldehyde type
AU3040784A (en) L-amino acids from alpha-keto acids
GB8925298D0 (en) Object tracking
EP0421439A3 (en) Ultrasonic atomiser
AU591459B2 (en) cDNA probe for the detection of bluetongue virus
GB8717072D0 (en) Induction-type compressor
AU6786981A (en) Selection stage of the ac signal having the greater amplitude
JPS57173019A (en) Attaching of mirror or the like
GB2249072B (en) Point of sale arrangement
ZA907896B (en) Substituted acrylamido-penicillanic esters
IL85803A0 (en) Gimbal assembly
ZA887993B (en) The tracking of objects
BG47918A1 (en) Isolated analogous signal adapter
GB8906868D0 (en) Improved plant-growth medium
IL106072A0 (en) Intermediates for the preparation of 4-aminoquinolines